Fundamentals of endothelial function for the clinical cardiologist.
By S. Verma, T. Anderson. Circulation, 2002
667 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Physiology
View Paper: https://www.semanticscholar.org/paper/f8a860c1cf98f009ca12b624af66139d2dce7496
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Physiology
Citations in the corpus
- Endothelial function testing as a biomarker of vascular disease. (2003, background): “The rationale for why endothelial function testing, either directly or indirectly, may serve as an indicator of vascular damage or disease is as follows: (1) The healthy endothelium is nonthrombogenic; (2) endothelial dysfunction occurs in response to vascular risk factors and is an early event in a”
- Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. (2018, background): “vasodilator and vasoconstrictor factors, which predisposes the vasculature towards a pro-thrombotic and pro-atherogenic phenotype, characterized by vasoconstrinction, leukocyte adhesion, platelet activation, mitogenesis, pro-oxidation, impaired coagulation, vascular inflammation, atherosclerosis and”
- Reactive Oxygen Species in Cardiovascular Disease (2011, background): “Also among the features of reperfusion injury is a burst of free radical formation that may continue for hours [230] and has been attributed to multiple sources including xanthine oxidase, activated neutrophils, electron leakage from mitochondria, catecholamine oxidation, cyclooxygenase and lipoxyge”
- Pathophysiology of Atherosclerosis (2022, background): “Briefly, when ECs lose their ability to maintain homeostasis, vessel walls are predisposed to vasoconstriction, lipid infiltration, leukocyte adhesion, platelet activation, and oxidative stress, among other things [23,24].”
- Endothelial dysfunction. (2004, background): “Vasoconstrictors include endothelin-1 (ET-1), angiotensin II (Ang II), thromboxane A2, and reactive oxygen species (ROS) (2,3).”